CVS HEALTH CORPORATION Proceeds from (Repayments of) Commercial Paper
CVS HEALTH CORPORATION (CVS) reported Proceeds from (Repayments of) Commercial Paper of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfCommercialPaper · last filed 2026-08-05
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for the quarter ending 2026-03-31 was $0.00.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for the quarter ending 2025-12-31 was -$1.25B, a 194.54% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for the quarter ending 2025-09-30 was -$1.79B, a 324.13% decline year-over-year.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for fiscal 2025 was -$2.12B, a 210.42% decline from fiscal 2024.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for fiscal 2024 was $1.92B, a 859.50% increase from fiscal 2023.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for fiscal 2023 was $200.00M.
- CVS HEALTH CORPORATION proceeds from (repayments of) commercial paper for fiscal 2022 was $0.00.
| Period end | Proceeds from (Repayments of) Commercial Paper 3 month | Proceeds from (Repayments of) Commercial Paper 6 month | Proceeds from (Repayments of) Commercial Paper 9 month | Proceeds from (Repayments of) Commercial Paper 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | -$1.25B derived: sum of 3 quarters · filed 2026-08-05 | -$3.04B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | -$1.25B derived: sum of 2 quarters · filed 2026-05-06 | -$3.04B derived: sum of 3 quarters · filed 2026-05-06 | -$1.26B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.25B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$3.04B derived: sum of 2 quarters · filed 2026-02-10 | -$1.26B derived: sum of 3 quarters · filed 2026-08-05 | -$2.12B 10-K · filed 2026-02-10 |
| 2025-09-30 | -$1.79B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$13.00M derived: sum of 2 quarters · filed 2026-08-05 | -$872.00M 10-Q · filed 2025-10-29 | $447.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.78B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $921.00M 10-Q · filed 2026-08-05 | $2.24B derived: sum of 3 quarters · filed 2026-08-05 | $3.04B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$859.00M 10-Q · filed 2026-05-06 | $460.00M derived: sum of 2 quarters · filed 2026-05-06 | $1.26B derived: sum of 3 quarters · filed 2026-05-06 | -$1.46B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.32B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $2.12B derived: sum of 2 quarters · filed 2026-02-10 | -$600.00M derived: sum of 3 quarters · filed 2026-02-10 | $1.92B 10-K · filed 2026-02-10 |
| 2024-09-30 | $800.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$1.92B derived: sum of 2 quarters · filed 2025-10-29 | $600.00M 10-Q · filed 2025-10-29 | $800.00M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$2.72B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$200.00M 10-Q · filed 2025-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-02-10 | -$1.00B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $2.52B 10-Q · filed 2025-05-01 | $2.72B derived: sum of 2 quarters · filed 2026-02-10 | $1.72B derived: sum of 3 quarters · filed 2026-02-10 | $2.72B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$800.00M derived: sum of 2 quarters · filed 2026-02-10 | $200.00M derived: sum of 3 quarters · filed 2026-02-10 | $200.00M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$1.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.00B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.00B 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-12 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-02 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |